Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment

Authors

Tamaro S. Hudson, National Institutes of Health, Bethesda, MD
Susan N. Perkins, University of Texas at Austin
Stephen D. Hursting, University of Texas at Austin
Heather A. Young, George Washington UniversityFollow
Young S. Kim, National Institutes of Health, Bethesda, MD
Tien-Chung Wang, University of Maryland, College Park
Thomas T.Y. Wang, US Department of Agriculture, Beltsville, MD

Document Type

Journal Article

Publication Date

4-2012

Journal

International Journal of Oncology

Volume

Volume 40, Issue 4

Inclusive Pages

1113-1121

Keywords

Cell-Matrix Junctions--drug effects; Cell-Matrix Junctions--genetics; Cell-Matrix Junctions--metabolism; Isothiocyanates--administration & dosage; Prostatic Neoplasms--drug therapy; Prostatic Neoplasms--genetics; Prostatic Neoplasms--pathology

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Hudson, T. S., Perkins, S. N., Hursting, S. D., Young, H. A., Kim, Y. S., Wang, T., & Wang, T. T. Y. (2012). Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment. International Journal of Oncology, 40(4), 1113-1121.

Peer Reviewed

1

Open Access

1